Uptown Research Institute

03/14/2024

Last week, the company MindMed announced the 12-week results from its Phase 2b study of MM120 (L*D D-Tartrate) in individuals with generalized anxiety disorder.

The results demonstrated that a single dose produced a clinical response in 65% of participants, with 48% of participants achieving clinical remission of symptoms. Importantly, these improvements lasted until the end of the 12-week study.

Based on these results, the FDA has granted Breakthrough Therapy Designation to MM120. This expedited review process is granted to drugs for which preliminary evidence has shown substantial improvement over existing therapies.

Uptown Research Institute is honored to have participated as a site for this Phase 2b study.

See the original press release here: https://ir.mindmed.co/news-events/press-releases/detail/137/mindmed-receives-fda-breakthrough-therapy-designation-and-announces-positive-12-week-durability-data-from-phase-2b-study-of-mm120-for-generalized-anxiety-disorder

06/01/2023

June is Alzheimer's and Brain Awareness Month

Get information and resources for Alzheimer's and other dementias from the Alzheimer's Association.

05/19/2023

Uptown Research Institute is passionate about making our research trials equitable and accessible for all. On Clinical Trials day, we send an overwhelming thank you to our team and those who participate in our studies!

Uptown Research is currently enrolling for clinical research trials for depression, anxiety, OCD, and schizophrenia. Interested in learning more? Call our recruitment manager at 773.989.8313 x116 to see if you qualify.

05/18/2023

Without clinical research, life changing breakthroughs would not be made for so many. On this day, we thank and celebrate our team at Uptown Research and other clinical researchers around the world!

Uptown Research Institute is currently enrolling for clinical research trials for depression, anxiety, OCD, and schizophrenia. Interested in learning more? Please call our recruitment manager at 773.989.8313 x116.

04/11/2023

Uptown Research Institute is now enrolling subjects for a schizophrenia study. Do you meet the listed criteria and are interested in learning more? Contact our recruitment manager for more details to see if you qualify.

02/21/2023

Do you experience symptoms of Generalized Anxiety? Uptown Research Institute is now enrolling subjects for a study that you might qualify for. Contact our recruitment manager at (773) 989-8313 x116 to learn more.

01/24/2023

Many patients who sign up for clinical research trials are unsure about what they can get out of it. Read the article below to learn more about why participating in a clinical research trail can benefit yourself and others, and explore our website to learn more about the clinical trials being offered at Uptown Research Institute today.
https://www.washingtonpost.com/wellness/2023/01/17/clinical-trials-cancer-information/?pwapi_token=eyJ0eXAiOiJKV1QiLCJhbGciOiJIUzI1NiJ9.eyJzdWJpZCI6IjM1MTI1NjEiLCJyZWFzb24iOiJnaWZ0IiwibmJmIjoxNjc0MDIxMzU5LCJpc3MiOiJzdWJzY3JpcHRpb25zIiwiZXhwIjoxNjc1MjMwOTU5LCJpYXQiOjE2NzQwMjEzNTksImp0aSI6IjU1MDNkMWFlLTk2NzctNDhiYS1iM2I1LTEyOTViM2U5NGQzYyIsInVybCI6Imh0dHBzOi8vd3d3Lndhc2hpbmd0b25wb3N0LmNvbS93ZWxsbmVzcy8yMDIzLzAxLzE3L2NsaW5pY2FsLXRyaWFscy1jYW5jZXItaW5mb3JtYXRpb24vIn0.AyBTDJT9zBPyw4YRKlKA5mnL99ewSCOan1izvsbdHAE

01/12/2023

This morning, our Principal Investigator, John Sonnenberg, Ph.D, was invited to talk on the Steve Cochran WLS-AM 890 radio talk-show. Follow the shared link to learn more about OCD. Visit our website to find out if you may qualify for our Obsessive Compulsive Disorder research study.

www.uptownresearchinstitute.com

Expert on OCD licensed clinical psychologist at Uptown Research Institute Dr. John Sonnenberg joins the Steve Cochran Show to explain how the brain can turn anything into an obsessive-compulsive loop, ways to help someone overcome this mental illness, and he debunks common stereotypes about OCD.

01/10/2023

Uptown Research Institute is now enrolling subjects for a Bipolar study. Interested in learning more? Contact our recruitment manager for more details to see if you qualify.